Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension

NCT06055452 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pre-Heart Failure
Hypertension

Interventions

DRUG: Empagliflozin 10 MG
DRUG: Placebo

Sponsor

China National Center for Cardiovascular Diseases